Interventional: Page 154

Novoste shows steep Q1 downturn, signs Guidant deal
By AuntMinnie.com staff writers
Vascular brachytherapy firm Novoste of Norcross, GA, has reported 2004 fiscal first-quarter revenue of $7 million, a sharp decline compared with $20.7 million reported in the same period last year.
April 21, 2004
MDS Nordion launches Theryttrex in E.U
By AuntMinnie.com staff writers
Canadian radioisotope supplier MDS Nordion of Kanata, ON, has introduced Theryttrex, the company's radiopharmaceutical-grade yttrium-90 (Y-90) product, at the German Congress of Nuclear Medicine in Rostock, Germany.
April 21, 2004
Guidant notches record Q1
By AuntMinnie.com staff writers
Interventional firm Guidant reported record 2004 fiscal first-quarter revenues of $934 million, up 9% compared with the $858 million in sales posted in the same period in 2003.
April 21, 2004
Cordis stent gets FDA panel recommendation
By AuntMinnie.com staff writers
Interventional technology developer Cordis has received an approval recommendation from the Circulatory System Devices Panel of the Food and Drug Administration for its Cordis Carotid System.
April 21, 2004
Cardinal unit to sell Graseby pump in the U.S.
By AuntMinnie.com staff writers
Cardinal Health's Radiation Management Services division has begun distributing the Graseby Medical 3400 Syringe Pump, used to administer intravenous drugs such as radiopharmaceuticals and chemotherapy drugs.
April 21, 2004
Guidant completes BVS acquisition
By AuntMinnie.com staff writers
Interventional device developer Guidant of Indianapolis has completed its acquisition of Bioabsorbable Vascular Solutions.
April 20, 2004
Boston Scientific shows strong Q1 gains
By AuntMinnie.com staff writers
Interventional device developer Boston Scientific of Natick, MA, has released financial results for its 2004 fiscal first quarter (end-March 31).
April 19, 2004
EP MedSystems gets FDA clearance
By AuntMinnie.com staff writers
Electrophysiology device developer EP MedSystems of West Berlin, NJ, has received Food and Drug Administration clearance for its line of "deflectable" diagnostic catheters.
April 18, 2004
AngioDynamics unveils Morpheus
By AuntMinnie.com staff writers
E-Z-EM subsidiary AngioDynamics has introduced Morpheus, a peripherally inserted central catheter (PICC) device used to obtain short- and long-term peripheral access to the central venous system for intravenous therapy and blood sampling, according to the Queensbury, NY-based firm.
April 14, 2004
Boston Scientific ups stake in Aspect
By AuntMinnie.com staff writers
Interventional device developer Boston Scientific of Natick, MA, has entered an agreement to purchase 500,000 shares of patient-monitoring device manufacturer Aspect Medical Systems, according to the company.
April 8, 2004
Cordis stent gets CE OK
By AuntMinnie.com staff writers
Interventional technology developer Cordis, a Johnson & Johnson subsidiary, has received CE Mark approval to market its Cypher Select sirolimus-eluting coronary stent in all member states of the European Union (EU), European Economic Area (EEA), and Switzerland.
April 7, 2004
Boston Scientific launches Sentinol
By AuntMinnie.com staff writers
Boston Scientific of Natick, MA, has introduced its self-expanding nitinol biliary stent system, Sentinol, to the U.S. market.
April 7, 2004
Previous Page
Page 154 of 185
Next Page